IP Library › Granted Patent US 11,285,240
Granted Patent B2
US 11,285,240 · App. 17/010,708 · Granted Mar 29, 2022

Particles

Inventors: Gregory M. Cruise (Rancho Santa Margarita, CA); Steve Plotkin (Aliso Viejo, CA); Xinping Wu (Aliso Viejo, CA)
Assignee: MicroVention, Inc.
A61L24/06A61L24/001C08F222/385A61L2430/36
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,285,240
App. No.
17/010,708
Granted
Mar 29, 2022
Kind
B2
Abstract

Embolic particles are described. The particles are reaction products of a prepolymer solution including at least one polyether macromer and an appropriate monomer.

Claims (26)

1. An embolic system including:

a composition including embolic particles having an organic polymer backbone including a reaction product of a prepolymer solution including:

a poly(ethylene glycol) diacrylamide macromer, a poly(ethylene glycol) diacrylate macromer, a poly(ethylene glycol) dimethacrylate macromer, a poly(ethylene glycol) dimethacrylamide macromer, or a combination thereof; and

at least one monomer,

wherein the embolic particles are configured to be larger than an opening of a mesh of a medical device.

2. The embolic system of claim 1 , wherein the opening is less than about 0.09 inches.

3. The embolic system of claim 1 , wherein the opening is less than about 0.08 inches.

4. The embolic system of claim 1 , wherein the opening is less than about 0.07 inches.

5. The embolic system of claim 1 , wherein the opening is less than about 0.06 inches.

6. The embolic system of claim 1 , wherein the opening is less than about 0.05 inches.

7. The embolic system of claim 1 , wherein the opening is less than about 0.04 inches.

8. The embolic system of claim 1 , wherein the medical device is a flow diverting stent.

9. The embolic composition of claim 1 , wherein the composition includes a visualization agent.

10. The embolic composition of claim 9 , wherein the visualization agent is particles of radiopaque materials or halogen containing monomers.

11. The embolic composition of claim 10 , wherein the halogen containing monomer is an iodine containing monomer.

12. The embolic composition of claim 11 , wherein the iodine containing monomer has a structure:

13. The embolic composition of claim 10 , wherein the particles of radiopaque materials include barium, bismuth, tantalum, platinum, and gold.

14. The embolic composition of claim 10 , wherein the particles of radiopaque materials include barium sulfate.

15. The embolic composition of claim 10 , wherein the particles of radiopaque materials include bismuth.

16. The embolic composition of claim 1 , wherein the at least one monomer includes ionic groups.

17. The embolic composition of claim 16 , wherein the monomer containing ionic groups is sodium acrylate.

18. The embolic composition of claim 1 , wherein the prepolymer solution further includes a crosslinker.

19. The embolic composition of claim 18 , wherein the crosslinker has a structure:

wherein each n is independently 1-20;

wherein d, e, and f are each independently 1-20; or

20. The embolic composition of claim 1 , wherein the macromer is a crosslinker.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 2, 2020
From: CRUISE, GREGORY M.; PLOTKIN, STEVE; WU, XINPING
To: MICROVENTION, INC.
Reel/Frame 053678/0528 →
Continuity (7)
Continuation 16717965 · Dec 17, 2019
Continuation 16505326 · Jul 8, 2019
Continuation 16184862 · Nov 8, 2018
Continuation 15878294 · Jan 23, 2018
Continuation 15081648 · Mar 25, 2016
Provisional Application 62138859 · Mar 26, 2015
Related Publication 20200397942A1 · Dec 24, 2020
Cited By (2)
US 12,364,786 US 12,447,228